Form 4 for PG Procter & Gamble
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001127602-24-025122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-03 | 2024-10-02 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale | $171.65 | -4,447 | 52.9K | -8% | -$763.3K |
| D | 2024-10-03 | 2024-10-01 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +56.6K | 56.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-02 | S | D | 4,447 | $171.65 | 52,872.09 | D | — | — | (F1) Shares sold to cover tax obligation upon settlement of Restricted Stock Unit Award. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-10-01 | A | A | 56,554 | $0.00 | 56,554 | D | $173.04 · 2027-10-01 to 2034-09-29 | 56,554 Common Stock |